(Reuters) - Procter & Gamble beat second-quarter sales estimates on Wednesday, as the Pantene shampoo maker's efforts to ...

Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales ...

(Reuters) -German specialty chemicals maker Lanxess said on Monday it expected its fourth-quarter core profit to exceed ...

M Company reported better-than-expected Q4 results, with net sales at $6.01B and adjusted EPS at $1.68. The company also provided solid 2025 forecast, ...

If you've been an investor for any length of time at all, then you've almost certainly been advised to start (and maybe even ...

Physician's Choice, a U.S. maker of supplements and probiotics, is exploring a sale that could value the company at over $500 million, according to sources familiar with the matter.

Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Thatchers has won a Court of Appeal trademark dispute with Aldi over its cloudy lemon cider. The Somerset cider maker had ...

Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, underscoring a gradual ...

French director Jacques Audiard's musical Emilia Pérez, about a Mexican drug lord, is a frontrunner for the Academy Awards.

Whether for brand-consistent marketing visuals or detailed character art, the Flux Pro Finetuning API enhances precision and adaptability.

Macsween of Edinburgh is developing a version of Scotland’s national dish in which sheep heart is substituted for lung ...